Sagility reported strong Q4 FY26 results with revenue of ₹20,243 million, up 29.1% YoY, and full-year revenue of ₹71,929 million, exceeding guidance.
The company guided for low double-digit constant currency growth in FY27 with adjusted EBITDA margins between 24% and 25%, citing strong demand for healthcare cost transformation.
Management highlighted $30.7 million in Q4 ACV signings, a final dividend of ₹0.10 per share, and plans for complete debt repayment by FY27 end.
Key trends include favorable Medicare Advantage rate increases, AI-led efficiency gains, and a strategic brand evolution emphasizing healthcare-first tech transformation.